Table 1. Baseline characteristics.
Patients, N=122 | |
---|---|
Median age, years (range) | 69 (35–92) |
Female sex, N (%) | 61 (50%) |
Serum monoclonal protein spike, median (range) (g/dl) | 2.0 (0.0–4.6) |
Urine monoclonal protein spike (n=96), N (%) | |
Not present | 29 (30) |
Detected on immunofixation only | 39 (41) |
Measurable but <0.5 g per 24 h | 24 (25) |
0.5 g per 24 h or more | 3 (3) |
Bone marrow plasma cell percentage, median (range) | 20 (4.0–100) |
Serum-free light-chain assay (n=91), N (%) | |
Abnormal κ/λ FLC ratio (<0.26 or >1.65) | 12 (13) |
Abnormal involved/uninvolved FLC ratio ⩾8 | 57 (63) |
Abnormal involved/uninvolved FLC ratio ⩾100 | 13 (14) |
Abbreviation: FLC, free light chain.